Slawin Kevin M.
Director at BELLICUM PHARMACEUTICALS, INC
- Sold, on record
- $4.5M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Feb 7, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BELLICUM PHARMACEUTICALS, INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedJul 15, 2016 2016
Sold 22,281 shares at $13.72 ($306k)
Slawin Kevin M., Chief Technology Officer
Sold 14% of holdings ($2.2M position)136,925 shares left0.9x usual sizeFiling
- 2 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedJul 18, 2016 +3 days
Sold 2,719 shares at $13.99 ($38k)
Slawin Kevin M., Chief Technology Officer
Sold 2% of holdings ($1.9M position)134,206 shares left0.1x usual sizeFiling
- 3 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedJul 27, 2016 +9 days
Sold 15,000 shares at $15.00 ($225k)
Slawin Kevin M., Chief Technology Officer
Sold 3.6% of holdings ($6.2M position)399,982 shares left0.7x usual sizeFiling
- 4 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusualAug 15, 2016 +19 days
Sold 67,000 shares at $19.31 ($1.3M)
Slawin Kevin M., Chief Technology Officer
Sold 40.6% of holdings ($3.2M position)98,206 shares left3.6x usual sizeFiling
- 5 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedSep 20, 2016 +36 days
Sold 4,584 shares at $20.01 ($92k)
Slawin Kevin M., Chief Technology Officer
Sold 4.6% of holdings ($2M position)95,564 shares left0.2x usual sizeFiling
- 6 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedSep 23, 2016 +3 days
Sold 23,416 shares at $20.11 ($471k)
Slawin Kevin M., Chief Technology Officer
Sold 21.8% of holdings ($2.2M position)84,206 shares left1.3x usual sizeFiling
- 7 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedDec 15, 2016 +83 days
Sold 30,000 shares at $15.45 ($464k)
Slawin Kevin M., Chief Technology Officer
Sold 8.5% of holdings ($5.5M position)324,982 shares left1.3x usual sizeFiling
- 8 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not statedFeb 7, 2017 +54 days
Sold 30,000 shares at $12.54 ($376k)
Slawin Kevin M., Director
Sold 9.2% of holdings ($4.1M position)294,982 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2017 | Feb 9, 2017 | BELLICUM PHARMACEUTICALS, INC | Director | Form 4 sale | 30,000 | $376k | 9.2% | Plan not stated | SEC |
| Dec 15, 2016 | Dec 19, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 30,000 | $464k | 8.5% | Plan not stated | SEC |
| Sep 23, 2016 | Sep 23, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 23,416 | $471k | 21.8% | Plan not stated | SEC |
| Sep 20, 2016 | Sep 20, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 4,584 | $92k | 4.6% | Plan not stated | SEC |
| Aug 15, 2016 | Aug 17, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 67,000 | $1.3M | 40.6% | Unusual | SEC |
| Jul 27, 2016 | Jul 29, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 15,000 | $225k | 3.6% | Plan not stated | SEC |
| Jul 18, 2016 | Jul 19, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 2,719 | $38k | 2.0% | Plan not stated | SEC |
| Jul 15, 2016 | Jul 19, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 22,281 | $306k | 14.0% | Plan not stated | SEC |
| Apr 22, 2016 | Apr 26, 2016 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 55,000 | $628k | 25.7% | Unusual | SEC |
| Nov 16, 2015 | Nov 18, 2015 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 24,000 | $496k | 11.5% | Plan not stated | SEC |
| Jul 15, 2015 | Jul 17, 2015 | BELLICUM PHARMACEUTICALS, INC | Chief Technology Officer | Form 4 sale | 6,000 | $120k | 3.6% | Plan not stated | SEC |